Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr.

Clin Chem. 2002 Oct;48(10):1835-43.

2.

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr.

Cancer Res. 2002 Jul 1;62(13):3609-14.

3.

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z.

Biostatistics. 2003 Jul;4(3):449-63.

PMID:
12925511
4.

[Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].

Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, He DC, Zhao XJ, Yang BX.

Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3172-5. Chinese.

PMID:
16405834
5.

Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.

Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, Yang BX, He DC, Zhao XJ.

Asian J Androl. 2006 Jan;8(1):45-51.

6.
7.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
8.

Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.

Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang ZH, Lv ML, Jia J, Zhang L.

Cancer. 2008 Feb 1;112(3):544-51.

9.

Prostate cancer biomarker discovery using high performance mass spectral serum profiling.

Oh JH, Lotan Y, Gurnani P, Rosenblatt KP, Gao J.

Comput Methods Programs Biomed. 2009 Oct;96(1):33-41. doi: 10.1016/j.cmpb.2009.04.003. Epub 2009 May 6.

PMID:
19423179
10.

Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Gao H, Zheng Z, Yue Z, Liu F, Zhou L, Zhao X.

Int J Mol Med. 2012 Nov;30(5):1061-8. doi: 10.3892/ijmm.2012.1113. Epub 2012 Aug 30.

PMID:
22941199
11.

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.

Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF 3rd.

J Urol. 2004 Oct;172(4 Pt 1):1302-5.

PMID:
15371828
13.

Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Zhu XD, Su F, Liang ZG, Li L, Qu S, Liang X, Wang Q, Liang SX, Chen L.

Int J Clin Oncol. 2014 Aug;19(4):579-85. doi: 10.1007/s10147-013-0621-y. Epub 2013 Sep 27.

PMID:
24072388
14.

Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.

Zhang YF, Wu DL, Guan M, Liu WW, Wu Z, Chen YM, Zhang WZ, Lu Y.

Clin Biochem. 2004 Sep;37(9):772-9.

PMID:
15329315
15.
16.

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S.

J Urol. 2003 Aug;170(2 Pt 1):442-6.

PMID:
12853795
17.

[Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].

Wu DL, Zhang YF, Guan M, Liu WW, Xu YM, Jin SB, Zhang J, Jin CR, Lü Y.

Zhonghua Zhong Liu Za Zhi. 2007 Apr;29(4):274-7. Chinese.

PMID:
17760254
18.

SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.

Skytt A, Thysell E, Stattin P, Stenman UH, Antti H, Wikström P.

Int J Cancer. 2007 Aug 1;121(3):615-20.

20.

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L.

Clin Chem. 2005 Jan;51(1):102-12.

Supplemental Content

Support Center